GLP-1 receptor agonism
Studied at the GLP-1 receptor, a widely distributed target distinct from the gut-restricted GLP-2 receptor.
These are results measured on this lot. Full material specification is in Know your compound.
GLP Compound
A long-acting GLP-1 receptor agonist analog studied in metabolic research.
$50.00 per vial with BOGO
Research use only — not for human or veterinary use, diagnostic or therapeutic.
Know your compound
GLP-1 S belongs to the incretin analog class: synthetic modifications of glucagon-like peptide-1, the gut hormone released in response to nutrient intake. Native GLP-1 is cleaved by dipeptidyl peptidase-IV within minutes, so every therapeutically relevant analog in this class carries substitutions that block that cleavage.
This compound additionally carries a fatty-acid chain that binds serum albumin — the same albumin-binding strategy seen in CJC-1295 DAC — which extends circulating exposure from minutes to a duration measured in days. Unlike GLP-2 TZ, which despite the similar name acts on a gut-restricted receptor, GLP-1 receptors are distributed across the pancreas, brain, heart and kidney, and the literature is correspondingly broad.
Supplied as a lyophilized powder for laboratory research use only, with a lot-specific Certificate of Analysis. Nothing on this page describes an approved therapy or a use in humans.
Read left to right from the N-terminus. Mass spectrometry checks each lot against this sequence — that result is the “Identity” line on the certificate.
What the molecule is.
How we know the material matches the label.
What arrives, and how it is kept.
What the literature examines
Summaries of what published research has investigated. Preclinical unless stated otherwise — not claims about this product.
Studied at the GLP-1 receptor, a widely distributed target distinct from the gut-restricted GLP-2 receptor.
Substitution at the cleavage site blocks the enzymatic degradation that limits native GLP-1 to a few minutes.
A fatty-acid conjugate binds serum albumin, the modification responsible for the extended exposure profile.
Certificate of Analysis
Not a brand-wide spec sheet — a lot-specific certificate from an independent laboratory, published before the lot ships and searchable by lot number forever.
Independent U.S. laboratory
Certificate of Analysis · RFX-2606-032
| Test | Specification | Result |
|---|---|---|
| Purity (HPLC) | ≥ 99.0% | 99.4% |
| Identity (LC-MS) | Conforms | Conforms |
| Appearance | White powder | Conforms |
| Net content | Label claim | Conforms |
Questions
No. GLP-1 S is not an FDA-approved drug and is not approved for human or veterinary use. It is supplied exclusively as a research material for laboratory use, and it is not intended to diagnose, treat, cure, or prevent any disease.
Yes. Every lot is assayed by an independent U.S. laboratory for purity and identity, and the certificate for the lot you receive is published in our COA library — you can read it before you order.
Purity is quantified by reverse-phase HPLC against a reference standard, and identity is confirmed by mass spectrometry. Both results appear on the lot certificate.
Lyophilized material is typically stored cold and protected from light. Handling and storage are the responsibility of the receiving laboratory; refer to the lot documentation for specifics.
Every second vial is free, sitewide and automatically. Add two vials and you pay for one; add six and you pay for three. Compounds can be mixed, there is no code, and there is no limit.
Orders are processed promptly and shipped with tracking. Free US shipping applies over $100; Priority shipping is $8.95 otherwise.
The guarantee
Have any lot independently re-tested. If the results don't match the purity printed on its published certificate, we refund the order in full — no returns, no argument.
Same research area